Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
1,359
Views
50
CrossRef citations to date
0
Altmetric
Original Articles

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis

Jing LiThe Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China
,
Xu GaoKey Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
,
Tao LuoKey Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
,
Jie WuThe Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China
,
Gang SunKey Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
,
Qingyun LiuKey Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China
,
Yuan JiangThe Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China
,
Yangyi ZhangThe Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China
,
Jian MeiThe Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China
&
Qian GaoKey Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaCorrespondence[email protected]
 show all
Pages 1-5 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anna Engström. (2016) Fighting an old disease with modern tools: characteristics and molecular detection methods of drug-resistant Mycobacterium tuberculosis. Infectious Diseases 48:1, pages 1-17.
Read now
Ahmed Abdel-Fattah Zayed, Tamer Mohamed Essam, Abdel-Gawad Mohamed Hashem & Ossama Mohamed El-Tayeb. (2015) ‘Supermutators’ found amongst highly levofloxacin-resistant E. coli isolates: a rapid protocol for the detection of mutation sites. Emerging Microbes & Infections 4:1, pages 1-8.
Read now

Articles from other publishers (48)

Aastha Saini, Rajneesh Dadwal, Rakesh Yadav, Rimjhim Kanaujia, Ashutosh Nath Aggarwal, Amit Arora & Sunil Sethi. (2024) Whole genome sequencing for the prediction of resistant tuberculosis strains from northern India. Indian Journal of Medical Microbiology 48, pages 100537.
Crossref
Yuri N. Khomyakov, Darya D. Zvyagintseva & Tatiana I. Khomyakova. (2023) Molecular bases of the interaction of <i>Mycobacteria tuberculosis complex</i> and anti-tuberculosis drugs: Current state of the problem and its epidemiological significance. Epidemiology and Infectious Diseases 28:2, pages 78-97.
Crossref
Yan Hu, Yuqing Chi, Xin Feng, Fengping Yu, Haoran Li, Yuanyuan Shang, Junhua Pan & Yu Pang. (2023) Comparison of the Diagnostic Performance of MeltPro and Next-Generation Sequencing in Determining Fluoroquinolone Resistance in Multidrug-Resistant Tuberculosis Isolates. The Journal of Molecular Diagnostics 25:6, pages 342-351.
Crossref
Zafran Khan, Daniya Ualiyeva, Khalid Jamal, Babar Ali, Fayaz Ahmad, Sanjeep Sapkota, Obed Boadi Amissah & Petuel Ndip Ndip Bate. (2023) Molecular diagnostics and potential therapeutic options for Mycobacterium tuberculosis: Where we stand. Medicine in Omics, pages 100022.
Crossref
Yangyi Zhang, Chenlei Yu, Yuan Jiang, Xubin Zheng, Lili Wang, Jing Li, Xin Shen & Biao Xu. (2023) Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment. Clinical Microbiology and Infection 29:3, pages 353-359.
Crossref
Yangyi Zhang, Yuan Jiang, Chenlei Yu, Jing Li, Xuhui Shen, Qichao Pan & Xin Shen. (2022) Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study. Frontiers in Public Health 10.
Crossref
Xiaocui Wu, Guangkun Tan, Jinghui Yang, Yinjuan Guo, Chengchen Huang, Wei Sha & Fangyou Yu. (2022) Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS. International Journal of Infectious Diseases 121, pages 47-54.
Crossref
Xiaofu ZhangXi ChenBin WangLei FuFengmin HuoTianhui GaoYu Pang, Yu LuQi Li. (2021) Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in Mycobacterium tuberculosis from Individuals Diagnosed with Preextensive Drug-Resistant Tuberculosis . Microbial Drug Resistance.
Crossref
Muralidhar Aaina, Kaliyaperumal Venkatesh, Brammacharry Usharani, Muthukumar Anbazhagi, Gerard Rakesh & Muthaiah Muthuraj. (2021) Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis. Journal of Respiration 2:1, pages 1-12.
Crossref
Jing Bi, Qinglong Guo, Xiangdong Fu, Juan Liang, Lidong Zeng, Min Ou, Juanjuan Zhang, Zhaoqin Wang, Yicheng Sun, Lei Liu & Guoliang Zhang. (2021) Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing. International Journal of Infectious Diseases 112, pages 189-194.
Crossref
Jalil Kardan-Yamchi, Sirus Amini, Gholamreza Hamzelou, Abbas Rahimi Foroushani, Arash Ghodousi, Daniela Maria Cirillo & Mohammad Mehdi Feizabadi. (2021) Assessment of the GenoType MTBDRsl VER 2.0 compared to the phenotypic drug susceptibility testing and whole genome sequencing for the rapid detection of resistance to fluoroquinolone and second-line injectable drugs among rifampicin-resistant Mycobacterium tuberculosis isolates. Archives of Microbiology 203:7, pages 3989-3996.
Crossref
Kanthesh M Basalingappa, Pugazhandhi B, Nagalambika P, Gopenath T S, Veena Gowda S, Karthikeyan M, Ashok G & S D K Shri Devi. (2021) Tuberculosis – An overview. Indian Journal of Microbiology Research 8:2, pages 96-101.
Crossref
Somanna Ajjamada Nachappa, Sumana M. Neelambike, Ahmad Sarikhani & Nallur B. Ramachandra. (2021) Simultaneous Detection of Drug-resistant Mutations in Mycobacterium tuberculosis and Determining their Role through In Silico Docking. Infectious Disorders - Drug Targets 21:1, pages 134-141.
Crossref
Bashir A. Sheikh, Basharat A. Bhat, Umar Mehraj, Wajahat Mir, Suhail Hamadani & Manzoor A. Mir. (2021) Development of New Therapeutics to Meet the Current Challenge of Drug Resistant Tuberculosis. Current Pharmaceutical Biotechnology 22:4, pages 480-500.
Crossref
Letemichael Negash Welekidan, Eystein Skjerve, Tsehaye Asmelash Dejene, Mengistu Welday Gebremichael, Ola Brynildsrud, Tone Tønjum & Solomon Abebe Yimer. (2021) Frequency and patterns of first- and second-line drug resistance-conferring mutations in Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in a cross-sectional study in Tigray Region, Ethiopia. Journal of Global Antimicrobial Resistance 24, pages 6-13.
Crossref
Yuan Cao, Heta Parmar, Rajiv L. Gaur, Deanna Lieu, Shobana Raghunath, Nova Via, Simone Battaglia, Daniela M. Cirillo, Claudia Denkinger, Sophia Georghiou, Robert Kwiatkowski, David Persing, David Alland & Soumitesh Chakravorty. (2021) Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum. Journal of Clinical Microbiology 59:3.
Crossref
D. V. Vаkhrushevа, T. V. Umpelevа, N. I. Eremeevа, L. S. Lаvrenchuk, S. Yu. Krаsnoborovа & А. E. Panova. (2020) Genetic polymorphism and phenotypic resistance of Mycobacterium tuberculosis to ofloxacin and moxifloxacin. Tuberculosis and Lung Diseases 98:11, pages 27-31.
Crossref
Pravin Kumar SinghUrmila SinghAmita Jain. (2020) Emergence of Specific gyr A Mutations Associated High-Level Fluoroquinolone-Resistant Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Cases in North India . Microbial Drug Resistance.
Crossref
Jalil Kardan-Yamchi, Hossein Kazemian, Simone Battaglia, Hamidreza Abtahi, Abbas Rahimi Foroushani, Gholamreza Hamzelou, Daniela Maria Cirillo, Arash Ghodousi & Mohammad Mehdi Feizabadi. (2020) Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran. Journal of Clinical Medicine 9:2, pages 465.
Crossref
Yuvaraj Chandramohan, Venkatesan Padmanaban, Ramalingam Bethunaickan, Srikanth Tripathy, Soumya Swaminathan & Uma Devi Ranganathan. (2019) In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates. Journal of Global Antimicrobial Resistance 19, pages 348-353.
Crossref
Amanda Mabhula & Vinayak Singh. (2019) Drug-resistance in Mycobacterium tuberculosis : where we stand . MedChemComm 10:8, pages 1342-1360.
Crossref
Marva Seifert, Edmund Capparelli, Donald G. Catanzaro & Timothy C. Rodwell. (2019) Using Mycobacterium tuberculosis Single-Nucleotide Polymorphisms To Predict Fluoroquinolone Treatment Response. Antimicrobial Agents and Chemotherapy 63:7.
Crossref
Jayshree Advani, Renu Verma, Oishi Chatterjee, Praveen Kumar Pachouri, Prashant Upadhyay, Rajesh Singh, Jitendra Yadav, Farah Naaz, Raju Ravikumar, Shashidhar Buggi, Mrutyunjay Suar, Umesh D. Gupta, Akhilesh Pandey, Devendra S. Chauhan, Srikanth Prasad Tripathy, Harsha Gowda & T. S. Keshava Prasad. (2019) Whole Genome Sequencing of Mycobacterium tuberculosis Clinical Isolates From India Reveals Genetic Heterogeneity and Region-Specific Variations That Might Affect Drug Susceptibility. Frontiers in Microbiology 10.
Crossref
Kristen V. DicksJason E. Stout. (2019) Molecular Diagnostics for Mycobacterium tuberculosis Infection . Annual Review of Medicine 70:1, pages 77-90.
Crossref
Farzam Vaziri, Thomas A. Kohl, Hasan Ghajavand, Mansour Kargarpour Kamakoli, Matthias Merker, Shima Hadifar, Sharareh Khanipour, Abolfazl Fateh, Morteza Masoumi, Seyed Davar Siadat & Stefan Niemann. (2019) Genetic Diversity of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis Isolates in the Capital of Iran, Revealed by Whole-Genome Sequencing. Journal of Clinical Microbiology 57:1.
Crossref
Trinh Quynh Mai, Elena MartinezRanjeeta MenonNguyen Thi Van AnhNguyen Tran HienBen J. MaraisVitali Sintchenko. (2018) Mycobacterium tuberculosis Drug Resistance and Transmission among Human Immunodeficiency Virus–Infected Patients in Ho Chi Minh City, Vietnam. The American Journal of Tropical Medicine and Hygiene 99:6, pages 1397-1406.
Crossref
Pierre Mahé & Maud Tournoud. (2018) Predicting bacterial resistance from whole-genome sequences using k-mers and stability selection. BMC Bioinformatics 19:1.
Crossref
Leticia P. de Oliveira, Zumira A. Carneiro, Camila M. Ribeiro, Maurício F. Lima, Drielly A. Paixão, Marcos Pivatto, Marcus V.N. de Souza, Letícia R. Teixeira, Carla D. Lopes, Sérgio de Albuquerque, Fernando R. Pavan & Wendell Guerra. (2018) Three new platinum complexes containing fluoroquinolones and DMSO: Cytotoxicity and evaluation against drug-resistant tuberculosis. Journal of Inorganic Biochemistry 183, pages 77-83.
Crossref
Kiran Chawla, Ajay Kumar, Vishnu Prasad Shenoy, Sanjiban Chakrabarty & Kapaettu Satyamoorthy. (2018) Genotypic detection of fluoroquinolone resistance in drug-resistant Mycobacterium tuberculosis at a tertiary care centre in south Coastal Karnataka, India. Journal of Global Antimicrobial Resistance 13, pages 250-253.
Crossref
H. M. Adnan Hameed, Md Mahmudul Islam, Chiranjibi Chhotaray, Changwei Wang, Yang Liu, Yaoju Tan, Xinjie Li, Shouyong Tan, Vincent Delorme, Wing W. Yew, Jianxiong Liu & Tianyu Zhang. (2018) Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains. Frontiers in Cellular and Infection Microbiology 8.
Crossref
Manoon Leechawengwongs, Therdsak Prammananan, Sarinya Jaitrong, Pamaree Billamas, Nampueng Makhao, Nongnard Thamnongdee, Arirat Thanormchat, Arisa Phurattanakornkul, Somcharn Rattanarangsee, Chate Ratanajaraya, Areeya Disratthakit & Angkana Chaiprasert. (2018) In Vitro Activity and MIC of Sitafloxacin against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis Isolated in Thailand . Antimicrobial Agents and Chemotherapy 62:1.
Crossref
Wifak Ennassiri, Sanae Jaouhari, Wafa Cherki, Reda Charof, Abdelkarim Filali-Maltouf & Ouafae Lahlou. (2017) Extensively drug-resistant tuberculosis (XDR-TB) in Morocco. Journal of Global Antimicrobial Resistance 11, pages 75-80.
Crossref
Anushka Naidoo, Kogieleum Naidoo, Helen McIlleron, Sabiha Essack & Nesri Padayatchi. (2017) A Review of Moxifloxacin for the Treatment of Drug‐Susceptible Tuberculosis. The Journal of Clinical Pharmacology 57:11, pages 1369-1386.
Crossref
Tao Luo, Jinning Yuan, Xuan Peng, Guoping Yang, Youjun Mi, Changfeng Sun, Chuhan Wang, Chunxi Zhang & Lang Bao. (2017) Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis. Journal of Antimicrobial Chemotherapy 72:7, pages 1893-1900.
Crossref
Devan Jaganath, H. Simon Schaaf & Peter R. Donald. (2017) Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis. Journal of Antimicrobial Chemotherapy 72:7, pages 1848-1857.
Crossref
Mohammad J. Nasiri, Mehri Haeili, Mona Ghazi, Hossein Goudarzi, Ali Pormohammad, Abbas A. Imani Fooladi & Mohammad M. Feizabadi. (2017) New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria. Frontiers in Microbiology 8.
Crossref
Keertan Dheda, Tawanda Gumbo, Gary Maartens, Kelly E Dooley, Ruth McNerney, Megan Murray, Jennifer Furin, Edward A Nardell, Leslie London, Erica Lessem, Grant Theron, Paul van Helden, Stefan Niemann, Matthias Merker, David Dowdy, Annelies Van Rie, Gilman K H Siu, Jotam G Pasipanodya, Camilla Rodrigues, Taane G Clark, Frik A Sirgel, Aliasgar Esmail, Hsien-Ho Lin, Sachin R Atre, H Simon Schaaf, Kwok Chiu Chang, Christoph Lange, Payam Nahid, Zarir F Udwadia, C Robert HorsburghJrJr, Gavin J Churchyard, Dick Menzies, Anneke C Hesseling, Eric Nuermberger, Helen McIlleron, Kevin P Fennelly, Eric Goemaere, Ernesto Jaramillo, Marcus Low, Carolina Morán Jara, Nesri Padayatchi & Robin M Warren. (2017) The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine 5:4, pages 291-360.
Crossref
Y. Gardee, A. W. Dreyer, H. J. Koornhof, S. V. Omar, P. da Silva, Z. Bhyat & N. A. Ismail. (2017) Evaluation of the GenoType MTBDR sl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa . Journal of Clinical Microbiology 55:3, pages 791-800.
Crossref
Jees Sebastian, Sharmada Swaminath, Rashmi Ravindran Nair, Kishor Jakkala, Atul Pradhan & Parthasarathi Ajitkumar. (2017) De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro . Antimicrobial Agents and Chemotherapy 61:2.
Crossref
Hassan Ravansalar, Keyvan Tadayon, Nader Mosavari, Mohamad Derakhshan & Kiarash Ghazvini. (2016) Genetic Diversity of Mycobacterium tuberculosis Complex Isolated from Patients in the Northeast of Iran by MIRU-VNTR and Spoligotyping. Jundishapur Journal of Microbiology In press:In press.
Crossref
Areeya Disratthakit, Therdsak Prammananan, Chanwit Tribuddharat, Iyarit Thaipisuttikul, Norio Doi, Manoon Leechawengwongs & Angkana Chaiprasert. (2016) Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates . Antimicrobial Agents and Chemotherapy 60:9, pages 5189-5197.
Crossref
Nele Coeck, Bouke C. de Jong, Maren Diels, Pim de Rijk, Elisa Ardizzoni, Armand Van Deun & Leen Rigouts. (2016) Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis . Journal of Antimicrobial Chemotherapy 71:5, pages 1233-1240.
Crossref
Tomasz Jagielski, Alina Minias, Jakko van Ingen, Nalin Rastogi, Anna Brzostek, Anna Żaczek & Jarosław Dziadek. (2016) Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria. Clinical Microbiology Reviews 29:2, pages 239-290.
Crossref
Jung-Yien Chien, Wei-Yih Chiu, Shun-Tien Chien, Chia-Jung Chiang, Chong-Jen Yu & Po-Ren Hsueh. (2016) Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates . Antimicrobial Agents and Chemotherapy 60:4, pages 2090-2096.
Crossref
Maha R. Farhat, Karen R. Jacobson, Molly F. Franke, Devinder Kaur, Alex Sloutsky, Carole D. Mitnick & Megan Murray. (2016) Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis. Journal of Clinical Microbiology 54:3, pages 727-733.
Crossref
L. Rigouts, N. Coeck, M. Gumusboga, W. B. de Rijk, K. J. M. Aung, M. A. Hossain, K. Fissette, H. L. Rieder, C. J. Meehan, B. C. de Jong & A. Van Deun. (2016) Specific gyrA gene mutations predict poor treatment outcome in MDR-TB . Journal of Antimicrobial Chemotherapy 71:2, pages 314-323.
Crossref
Michal Wozniak, Jerzy Tiuryn & Limsoon Wong. (2014) GWAMAR: Genome-wide assessment of mutations associated with drug resistance in bacteria. BMC Genomics 15:S10.
Crossref
Andrej Trauner, Sonia Borrell, Klaus Reither & Sebastien Gagneux. (2014) Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy. Drugs 74:10, pages 1063-1072.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.